Pregenen
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs.
Employees
Enterprise value
$140m
| Date | Investors | Amount | Round |
|---|---|---|---|
$140m Valuation: $140m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads